-
摘要:
目的 观察麻醉诱导前静脉预注维库溴铵对芬太尼诱发咳嗽(fentanyl-induced cough, FIC)的抑制效果。 方法 160例患者随机分为两组, 对照组静脉注射生理盐水1 ml; 维库溴铵预注组静脉注射维库溴铵0.01 mg/kg, 均采用左侧肘正中静脉注射; 两组均于5 min后静脉注射芬太尼3 μg/kg, 注射时间2 s。记录两组患者咳嗽发生的次数和出现时间, 并根据咳嗽发生次数进行严重程度分级。在注射生理盐水或维库溴铵时、注射芬太尼时及注射后1、2 min分别记录血压、心率、呼吸和脉搏血氧饱和度及药物不良反应。 结果 两组患者性别构成差异无统计学意义(P=0.081)。两组比较, 维库溴铵组芬太尼诱发咳嗽的发生率(21.3%, 17/80)明显低于对照组(42.5%, 34/80)(P=0.004);维库溴铵组芬太尼诱发中度和重度咳嗽患者为35.3%(6/17), 明显少于对照组的55.9%(19/34)(P < 0.005);咳嗽出现时间和血流动力学参数比较两组差异无统计学意义。 结论 维库溴铵预处理能有效降低芬太尼诱发咳嗽的发生率和强度。 Abstract:Objective To observe the effect of intravenous vecuronium pretreatment on fentanyl-induced cough (FIC). Methods Totally 160 American Society of Anesthesiologists class I-II patients, aged 18-65 years within normal weight, scheduled for elective surgery, were randomly assigned to receive intravenous vecuronium 0.01 mg/kg (pretreatment group) or placebo (normal saline, control group) 5 minutes prior to the administration of fentanyl 3 μg/kg in a randomized and double-blind fashion. Any episode of cough was classified as coughing, and graded as mild (1-2), moderate (3-4), or severe (5 or more). We recorded the timing and severity of cough and monitored the vital signs and discomforts such as dizziness, tinnitus, nausea/vomiting, apnea, and dysrhythmia. Results The gender distribution showed no significant difference between two groups (P=0.081). The incidence of cough was 21.3% (17/80) in pretreatment group and 42.5% (34/80) in control group (P=0.004). The incidence of moderate and severe cough was significantly higher in the control group (19/34, 55.9%) than in pretreatment group (6/17, 35.3%) (P < 0.005). There was no significant difference between these two groups in the timing of cough. Vital signs were stable in both groups and no difference was shown in discomforts. Conclusion Vecuronium pretreatment can effectively reduce the incidence and severity of FIC. -
Key words:
- fentanyl /
- cough /
- vecuronium /
- pretreatment
-
表 1 患者一般资料
分组 n 年龄(岁,x±s) 男/女 体重(kg,x±s) ASA分级(Ⅰ/Ⅱ) 对照组 80 36 ± 9 20 /60 59 ± 9 54 /26 维库溴铵预注组 80 39 ± 9 20 /60 60 ± 9 52 /28 ASA:美国麻醉医师协会 表 2 芬太尼诱发咳嗽的发生率、严重度和出现时间
分组 咳嗽发生率(%) 咳嗽严重度(%) 咳嗽出现时间(s,x±s) 轻度 中度 重度 对照组 42. 5 44. 1 11. 8 44. 1 23. 40 ± 5. 21 维库溴铵预注组 21. 3* 64. 7* 35. 3* 0* 24. 50 ± 5. 39 与对照组比较,* P<0. 05 表 3 维库溴铵预注组与对照组血流动力学变化(x±s)
分组 监测时间 收缩压(mm Hg) 舒张压(mm Hg) 心率(次/min) 对照组 给药前 118. 9 ± 18. 1 72. 3 ± 10. 2 80. 7 ± 14. 1 给药1 min 115. 5 ± 13. 9 69. 3 ± 10. 7 78. 1 ± 15. 3 给药2 min 114. 2 ± 13. 7 67. 4 ± 9. 7 77. 5 ± 15. 8 维库溴铵预注组 给药前 124. 4 ± 15. 3 75. 3 ± 9. 9 77. 6 ± 12. 6 给药1 min 119. 2 ± 15. 3 71. 2 ± 11. 0 77. 4 ± 14. 4 给药2 min 118. 4 ± 16. 9 70. 4 ± 11. 2 74. 8 ± 13. 5 -
[1] Fukuda K. Opioids[M]//Miller RD, ed. Miller's Anesthesia. 7th ed. New York: Churchill Livingstone, 2009: 783. [2] Elcock DH. Fentanyl-induced cough[J]. Anaesthesia, 2010, 65:536-537. doi: 10.1111/j.1365-2044.2010.06321.x [3] Hung KC. Incidence of fentanyl-induced cough and injection speed[J]. Acta Anaesthesiol Scand, 2009, 53:1227. http://europepmc.org/abstract/MED/19737185 [4] Uvelin A, Pakic G. Guidelines for prevention of fentanyl-induced cough[J]. Acta Anaesthesiol Scand, 2009, 53:1228-1229. doi: 10.1111/j.1399-6576.2009.02041.x [5] Lin CS, Sun WZ, Chan WH, et al. Intravenous lidocaine and ephedrine, but not propol, suppress fentanyl-induced cough[J]. Can J Anesth, 2005, 51:654-659. http://europepmc.org/abstract/MED/15310631 [6] Hung KC, Chen CW, Lin VCH, et al. The effect of preemptive minimal dose fentanyl and coughing[J]. Anaesthesia, 2010, 65:4-7. doi: 10.1111/j.1365-2044.2009.06109.x [7] Han JI, Lee H, Kim CH, et al. The frequency of fentanylinduced cough in children and its effects on tracheal intubation[J]. Clin Anesth, 2010, 22:3-6. doi: 10.1016/j.jclinane.2009.01.019 [8] Lin JA, Chen FC, Lee MS, et al. Intravenous dexamethasone pretreatment reduces fentanyl-induced cough[J]. J Formos Med Assoc, 2007, 106:649-655. doi: 10.1016/S0929-6646(08)60022-4 [9] 张志永, 黄宇光.芬太尼咳嗽反射的研究及其治疗进展[J].临床麻醉学杂志, 2007, 23:84-85. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcmzxzz200701039 [10] Foldes FF. Rapid tracheal intubation with nondepolarizing neuromuscular blocking drugs:the priming principle (letter)[J]. Br J Anasesth, 1984, 56:663. http://europepmc.org/abstract/MED/6721974 [11] Kopman AF, Khan NA, Neuman GG. Precurarization and priming:a theoretical analysis of safety and timing[J]. Anesth Analg, 2001, 93:1253-1256. http://www.ncbi.nlm.nih.gov/pubmed/11682407
计量
- 文章访问数: 156
- HTML全文浏览量: 56
- PDF下载量: 2
- 被引次数: 0